伝統医薬データベース　

サイト内検索結果「」

全16,951件中、3,341件～3,360件を表示しています。
[1] ・・・ [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] ・・・ [848]

(3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-3-(((2R,4S,5R,6R)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-13-methyl-17-(5-oxo-2,5-dihydrofuran-3-yl)hexadecahydro-1H-cyclopenta[a]phenant

6682. [TOPICS] 『2022 (探索研究)』

2022 (探索研究) 探索研究論文 - Ngwe Tun M. M., Toume K., Luvai E., Nwe K. M., Mizukami S., Hirayama K., Komatsu K., Morita K.: The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 inf

6683. [生薬成分の代謝] 代謝物『(3R,4S,5R)-3,4,5-trihydroxycyclohex-1-enecarboxylic acid』

(3R,4S,5R)-3,4,5-trihydroxycyclohex-1-enecarboxylic acid (3R,4S,5R)-3,4,5-trihydroxycyclohex-1-enecarboxylic acid 138-59-0 C7H10O5 174.153 174.0528 175.0607 173.045 Quinic acid 代謝物

6684. [生薬成分の代謝] 代謝物『(-)-Enterodiol』

(2R,3R)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol (-)-Enterodiol 80226-00-2 C18H22O4 302.37 302.1518 303.1596 301.144 Secoisolariciresinol 代謝物

6685. [TOPICS] 『2014 (探索研究)』

2014 (探索研究) 探索研究論文

6686. [生薬成分の代謝] 代謝物『(R)-2-(3-(3,4-dihydroxyphenyl)-2-hydroxypropyl)benzene-1,3,5-triol』

(R)-2-(3-(3,4-dihydroxyphenyl)-2-hydroxypropyl)benzene-1,3,5-triol (R)-2-(3-(3,4-dihydroxyphenyl)-2-hydroxypropyl)benzene-1,3,5-triol C15H16O6 292.288 292.0947 293.1025 291.0869 Epicatechine 代謝物

6687. [生薬成分の代謝] 代謝物『(S)-5-(2-hydroxy-3-(2,4,6-trihydroxyphenyl)propyl)benzene-1,2,3-triol』

(S)-5-(2-hydroxy-3-(2,4,6-trihydroxyphenyl)propyl)benzene-1,2,3-triol (S)-5-(2-hydroxy-3-(2,4,6-trihydroxyphenyl)propyl)benzene-1,2,3-triol C15H16O7 308.288 308.0896 309.0974 307.0818 Epigallocatech

6688. [生薬成分の代謝] 代謝物『(S)-5-(2-hydroxy-3-(2,4,6-trihydroxyphenyl)propyl)benzene-1,2,3-triol』

(S)-5-(2-hydroxy-3-(2,4,6-trihydroxyphenyl)propyl)benzene-1,2,3-triol (S)-5-(2-hydroxy-3-(2,4,6-trihydroxyphenyl)propyl)benzene-1,2,3-triol C15H16O7 308.288 308.0896 309.0974 307.0818 Gallocatechine

6689. [生薬成分の代謝] 代謝物『(R)-3-(3,4-dihydroxyphenyl)-2-hydroxy-1-(2,4,6-trihydroxyphenyl)propan-1-one』

(R)-3-(3,4-dihydroxyphenyl)-2-hydroxy-1-(2,4,6-trihydroxyphenyl)propan-1-one (R)-3-(3,4-dihydroxyphenyl)-2-hydroxy-1-(2,4,6-trihydroxyphenyl)propan-1-one C15H14O7 306.272 306.074 307.0818 305.0661 T

6690. [TOPICS] 『2018 (探索研究)』

2018 (探索研究) 探索研究論文 - Fujii E., Inada Y., Kakoki M., Nishimura N., Endo S., Fujiwara S., Wada N., Kawano Y., Okuno Y., Sugimoto T., Hata H.: Bufalin induces DNA damage response under hypoxic condition

6691. [生薬成分の代謝] 代謝物『Quinic acid』

(1S,3R,4S,5R)-1,3,4,5-tetrahydroxycyclohexanecarboxylic acid Quinic acid 77-95-2 C7H12O6 192.169 192.0634 193.0712 191.0556 Quinic acid 代謝物

6692. [TOPICS] 『2013 (探索研究)』

2013 (探索研究) 探索研究論文

6693. [生薬成分の代謝] 代謝物『(R)-2-(3-(3,4-dihydroxyphenyl)-2-hydroxypropyl)benzene-1,3,5-triol』

(R)-2-(3-(3,4-dihydroxyphenyl)-2-hydroxypropyl)benzene-1,3,5-triol (R)-2-(3-(3,4-dihydroxyphenyl)-2-hydroxypropyl)benzene-1,3,5-triol C15H16O6 292.288 292.0947 293.1025 291.0869 Catechine 代謝物

6694. [生薬成分の代謝] 代謝物『(+)-(2R, 3R)-Taxifolin』

(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychroman-4-one (+)-(2R, 3R)-Taxifolin 480-18-2 C15H12O7 304.256 304.0583 305.0661 303.0505 Taxifolin 代謝物

6695. [生薬成分の代謝] 代謝物『Trigoneline』

1-methylpyridin-1-ium-3-carboxylate Trigoneline 535-83-1 C7H7NO2 137.138 137.0477 138.0555 136.0399 Trigonelline 代謝物

6696. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 40 mg/kg 7.96 ± 2.7 h 1523.7 ± 448.9 ng∙h∙ml^-1 0-limit 24.39 ± 6.3 h 4.33 ± 3.2 h a p< 0.05, b p< 0.01 compared with conventional rats; Data are expressed as means±S

6697. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 50 mg/kg 30 min 100 ± 14.0 pmol/ml 8652 pmol・min/ml 0-10 h Saikosaponin 代謝パラメータ

6698. [生薬成分の代謝] 代謝物『3-(3, 4-Dihydroxyphenyl)-propionic acid』

3-(3,4-dihydroxyphenyl)propanoic acid 3-(3, 4-Dihydroxyphenyl)-propionic acid 1078-61-1 C9H10O4 182.176 182.0579 183.0657 181.0501 Caffeic acid 代謝物

6699. [生薬成分の代謝] 代謝物『Isophorbol』

(1aR,1bS,4aS,7aS,7bS,8R,9R,9aS)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1b,4,4a,7a,7b,8,9,9a-octahydro-1H-cyclopropa[3,4]benzo[1,2-e]azulen-5(1aH)-one Isophorbol 26241-63-4 C20H2

6700. [生薬成分の代謝] 代謝物『2-((7R,11R)-3-hydroxy-3,7,11,15-tetramethylhexadecyl)-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione』

2-((7R,11R)-3-hydroxy-3,7,11,15-tetramethylhexadecyl)-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione 2-((7R,11R)-3-hydroxy-3,7,11,15-tetramethylhexadecyl)-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione C

[1] ・・・ [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] ・・・ [848]
全16,951件中、3,341件～3,360件を表示しています。

ページの上へ戻る

TOPICS

生薬

漢方

試験薬物

遺伝子解析情報

化学分析情報

活性試験情報

生薬成分の代謝情報

探索研究